Biocogent explains why it is critical for microbiome-based innovations to be promoted and conveyed to the consumer with clarity and an appreciation for the sophistication of the subject matter and technology
Currently, the skin microbiome is one of the most popular trending topics within the cosmetic care industry. Briefly, the skin microbiome represents the collective genetic content presented by the microbial species that inhabit the various regions of the skin – the skin microbiota. This diverse community of microorganisms includes bacteria, fungi, protists, archaea, and viruses.1
Disruptions in the normal homeostatic levels of these microbes, what is known as dysbiosis, can have significant downstream impacts on skin health. Indeed, the cosmetic care industry has become engrossed in the era of the skin microbiome with the field of microbiological research continuing to produce astounding discoveries implicating microbial inhabitants in the molecular pathogenesis of multiple skin conditions.
These scientific findings are being reported at an unrelenting pace. As such, the cosmetic care industry has marshaled considerable efforts to design, develop, and launch products imbued with microbiome modulatory activities.2,3 Furthermore, according to MarketDigits, the global market for human microbiome-based products will soar to approximately $2.5 billion by the year 2030.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
